Ventral rectopexy can be performed robotically with only limited trauma for the patient, making its performance in an ambulatory setting potentially interesting. The aim of this study is to report our preliminary experience with ambulatory robotic ventral rectopexy in consecutive patients.

Ten consecutive patients underwent robotic ventral rectopexy for total rectal prolapse (n=8) or symptomatic enterocele (n=2) between February 2014 and April 2015. Patients were selected for outpatient treatment based on criteria of patient motivation, favorable social conditions, and satisfactory general condition. Patient characteristics, technical results and cost were reported.

The mean operating time was 94minutes (range: 78–150). The average operating room occupancy time was 254minutes (222–339). There were no operative complications, conversion to laparotomy, or postoperative complication. The average duration of hospital stay was 11 (8–32) hours. Two patients required hospitalization: one for persistent pain and the other for urinary retention. The average maximum pain score recorded on postoperative day 1 was 2/10 on a visual analog scale (range: 0–5/10). Estimated average cost (excluding amortization of the purchase of the robot) was €9088 per procedure.

Ambulatory management of robotic ventral rectopexy is feasible and safe.